Physician

Peter Kung, M.D.

According to 2025 Medicare claims, Peter Kung, M.D. (NPI: 1225169279) practices orthopedic surgery in the Longview-Kelso, WA market, with the plurality of this provider's patient population coming from Cowlitz, WA. This provider's primary affiliated billing organization is LONGVIEW ORTHOPEDIC ASSOCIATES, PLLC (NPI: 1003865072; TIN: 202707510) and primary practice location at 98632-2465. Kung is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Kung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 1,682 HCPCS/CPT codes, and received $122,746 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 503 prescription claims across 252 beneficiaries totaling $5,662 in drug costs, led by Oxycodone Hcl (Oxycodone Hcl). 2023 DME data shows 15 claims. Open Payments data shows 4 records totaling $1,116. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,134 and ending at $5,662. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	293	1,078	$134,142
2016	285	1,765	$125,744
2017	265	1,331	$143,735
2018	310	1,358	$122,924
2019	337	1,580	$137,150
2020	325	1,317	$141,693
2021	347	1,860	$145,251
2022	295	1,905	$147,364
2023	313	2,390	$152,286
2024	351	1,682	$122,746

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	159	270	$5,134
2016	160	301	$5,361
2017	170	296	$4,851
2018	165	272	$3,874
2019	187	330	$3,190
2020	177	282	$2,341
2021	192	359	$3,887
2022	221	492	$4,262
2023	325	694	$9,220
2024	252	503	$5,662

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	27	29	$2,307
2016	28	29	$2,071
2017	15	15	$1,064
2018	16	16	$1,309
2019	22	23	$1,925
2020	11	11	$857
2021	N/R	N/R	N/R
2022	13	13	$1,165
2023	15	15	$1,354
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	78	78	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	118	144	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	79	89	$61
20610	Aspiration and/or injection of fluid from large joint	96	116	$50
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	79	380	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone Hcl	Oxycodone Hcl	162	548	$957
Ondansetron Odt	Ondansetron	62	354	$537
Pantoprazole Sodium	Pantoprazole Sodium	82	2,445	$479
Ondansetron Hcl	Ondansetron Hcl	87	335	$381
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	122	$221

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$1,116	Arthrex, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter Kung, M.D.?

Tedicare shows public-source Medicare data for Peter Kung, M.D. (NPI 1225169279), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter Kung, M.D. have ACO affiliation data?

Peter Kung, M.D. is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Peter Kung, M.D.?

Peter Kung, M.D. is linked to LONGVIEW ORTHOPEDIC ASSOCIATES, PLLC (billing NPI 1003865072) in the available physician profile data.

Does Peter Kung, M.D. have Open Payments data?

Peter Kung, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.